DELSIA, an independent not-for-profit affiliate of Autism Speaks, will focus on accelerating the translation of scientific breakthroughs into products that will improve quality of life and health for those affected by autism.
You asked. We're delivering – right to your inbox. Subscribe to our new bi-weekly email digest of the top science news, perspective and feature stories from Autism Speaks. We hope you'll enjoy this resource and invite your friends to do the same. Look for your first issue August 10th.
Clara Lajonchere, Ph.D., Autism Speaks vice president for clinical programs, will be a featured speaker at the biannual conference of the Autism Research Institute (ARI), October 13-14, in Anaheim, Calif.
Many ACE Grants Based on Autism Speaks 'Seed' Money
Unexpected Gene Functions Shown in Initial Studies
High-Priority Research Will Study the Impact of the Proposed DSM-5 on Autism Diagnosis and much more!
The deal will pool the resources of Roche, the Swiss pharmaceutical giant, and Seaside Therapeutics, a private 30-employee company based in Cambridge, Mass.
A new study from the UC Davis M.I.N.D. Institute found that women who ran a fever during pregnancy had twice the risk of having a baby with autism. The study offered an easy fix, too: Women who controlled the fever with Tylenol or a similar fever-reducing medication eliminated the risk. PMID 22562209.
Brings Together More Than 1800 Participants From Around the World to Discuss the Latest Findings on the Causes, Treatments and Diagnoses of Autism
In November 2011, scientists from around the world gathered in Arlington, Virginia, to discuss how the emerging picture of autism brain pathways can lead to effective treatments for those struggling with disabling symptoms.
Pharmaceutical Companies, Advocacy Organizations, and Universities Join Forces to Discover New Drugs and Assess Novel Treatment Approaches for Autism